Potential Neurotoxicity of Tryptophan

  1. ANDREW FREESE;
  2. KENTON J. SCHWARTZ; and
  3. MATTHEW DURING, M.D.
  1. Massachusetts Institute of Technology;
    Cambridge, MA 02139
    Harvard Medical School;
    Boston, MA 02114
  2. Boston University School of Medicine;
    Boston, MA 02118
    Harvard Medical School;
    Boston, MA 02114
  3. Yale University School of Medicine;
    New Haven, CT 06510
    Massachusetts General Hospital-Harvard Medical School;
    Boston, MA 02114

    Excerpt

    To the editor: The precursor relationship of plasma or brain tryptophan levels to the bioactive tryptophan metabolite, serotonin, has been well characterized (1). Indeed, based on this relationship, therapeutic interventions for a number of disorders, including insomnia, depression, obesity, hypertension, and aggression, have been established. Because of media coverage, public self-administration of high doses of tryptophan bought at health food stores is common.

    Although tryptophan is a precursor for serotonin biosynthesis, the metabolism of tryptophan is more complex, occurring through a branched pathway. Various studies have shown that increased plasma and brain levels of tryptophan not only augment levels of

    « Previous | Next Article »Table of Contents